 | • レポートコード：QFJ1-5668 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、伴侶動物用医薬品＆ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、ワクチン）、用途別市場規模（犬、猫、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・伴侶動物用医薬品＆ワクチンの市場動向 ・企業の競争状況、市場シェア ・伴侶動物用医薬品＆ワクチンの種類別市場規模と予測2016-2027（医薬品、ワクチン） ・伴侶動物用医薬品＆ワクチンの用途別市場規模と予測2016-2027（犬、猫、その他） ・伴侶動物用医薬品＆ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・伴侶動物用医薬品＆ワクチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・伴侶動物用医薬品＆ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・伴侶動物用医薬品＆ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・伴侶動物用医薬品＆ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Zoetis、Boehringer Ingelheim、Merck Animal Health、Elanco Animal Health、Bayer Animal Health、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Meiji、Ouro Fino Saude、Parnell） ・結論 |
In this report, we study companion animals Medicines and Vaccines
Market Analysis and Insights: Global Companion Animals Medicines and Vaccines Market
The global Companion Animals Medicines and Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Animals Medicines and Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Animals Medicines and Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Animals Medicines and Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Animals Medicines and Vaccines market.
Global Companion Animals Medicines and Vaccines Scope and Market Size
Companion Animals Medicines and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Animals Medicines and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medicines
Vaccines
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicines
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Companion Animals Medicines and Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Animals Medicines and Vaccines Market Perspective (2016-2027)
2.2 Companion Animals Medicines and Vaccines Growth Trends by Regions
2.2.1 Companion Animals Medicines and Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Companion Animals Medicines and Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Companion Animals Medicines and Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Companion Animals Medicines and Vaccines Industry Dynamic
2.3.1 Companion Animals Medicines and Vaccines Market Trends
2.3.2 Companion Animals Medicines and Vaccines Market Drivers
2.3.3 Companion Animals Medicines and Vaccines Market Challenges
2.3.4 Companion Animals Medicines and Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animals Medicines and Vaccines Players by Revenue
3.1.1 Global Top Companion Animals Medicines and Vaccines Players by Revenue (2016-2021)
3.1.2 Global Companion Animals Medicines and Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Companion Animals Medicines and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Animals Medicines and Vaccines Revenue
3.4 Global Companion Animals Medicines and Vaccines Market Concentration Ratio
3.4.1 Global Companion Animals Medicines and Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animals Medicines and Vaccines Revenue in 2020
3.5 Companion Animals Medicines and Vaccines Key Players Head office and Area Served
3.6 Key Players Companion Animals Medicines and Vaccines Product Solution and Service
3.7 Date of Enter into Companion Animals Medicines and Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animals Medicines and Vaccines Breakdown Data by Type
4.1 Global Companion Animals Medicines and Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Companion Animals Medicines and Vaccines Forecasted Market Size by Type (2022-2027)
5 Companion Animals Medicines and Vaccines Breakdown Data by Application
5.1 Global Companion Animals Medicines and Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Companion Animals Medicines and Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Companion Animals Medicines and Vaccines Market Size (2016-2027)
6.2 North America Companion Animals Medicines and Vaccines Market Size by Type
6.2.1 North America Companion Animals Medicines and Vaccines Market Size by Type (2016-2021)
6.2.2 North America Companion Animals Medicines and Vaccines Market Size by Type (2022-2027)
6.2.3 North America Companion Animals Medicines and Vaccines Market Size by Type (2016-2027)
6.3 North America Companion Animals Medicines and Vaccines Market Size by Application
6.3.1 North America Companion Animals Medicines and Vaccines Market Size by Application (2016-2021)
6.3.2 North America Companion Animals Medicines and Vaccines Market Size by Application (2022-2027)
6.3.3 North America Companion Animals Medicines and Vaccines Market Size by Application (2016-2027)
6.4 North America Companion Animals Medicines and Vaccines Market Size by Country
6.4.1 North America Companion Animals Medicines and Vaccines Market Size by Country (2016-2021)
6.4.2 North America Companion Animals Medicines and Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Companion Animals Medicines and Vaccines Market Size (2016-2027)
7.2 Europe Companion Animals Medicines and Vaccines Market Size by Type
7.2.1 Europe Companion Animals Medicines and Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Companion Animals Medicines and Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Companion Animals Medicines and Vaccines Market Size by Type (2016-2027)
7.3 Europe Companion Animals Medicines and Vaccines Market Size by Application
7.3.1 Europe Companion Animals Medicines and Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Companion Animals Medicines and Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Companion Animals Medicines and Vaccines Market Size by Application (2016-2027)
7.4 Europe Companion Animals Medicines and Vaccines Market Size by Country
7.4.1 Europe Companion Animals Medicines and Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Companion Animals Medicines and Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Companion Animals Medicines and Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Type
8.2.1 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Application
8.3.1 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Region
8.4.1 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Animals Medicines and Vaccines Market Size (2016-2027)
9.2 Latin America Companion Animals Medicines and Vaccines Market Size by Type
9.2.1 Latin America Companion Animals Medicines and Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Companion Animals Medicines and Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Companion Animals Medicines and Vaccines Market Size by Type (2016-2027)
9.3 Latin America Companion Animals Medicines and Vaccines Market Size by Application
9.3.1 Latin America Companion Animals Medicines and Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Companion Animals Medicines and Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Companion Animals Medicines and Vaccines Market Size by Application (2016-2027)
9.4 Latin America Companion Animals Medicines and Vaccines Market Size by Country
9.4.1 Latin America Companion Animals Medicines and Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Companion Animals Medicines and Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animals Medicines and Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type
10.2.1 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application
10.3.1 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country
10.4.1 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animals Medicines and Vaccines Introduction
11.1.4 Zoetis Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Companion Animals Medicines and Vaccines Introduction
11.2.4 Boehringer Ingelheim Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Details
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Companion Animals Medicines and Vaccines Introduction
11.3.4 Merck Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Details
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Companion Animals Medicines and Vaccines Introduction
11.4.4 Elanco Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Details
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Companion Animals Medicines and Vaccines Introduction
11.5.4 Bayer Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.5.5 Bayer Animal Health Recent Development
11.6 Virbac
11.6.1 Virbac Company Details
11.6.2 Virbac Business Overview
11.6.3 Virbac Companion Animals Medicines and Vaccines Introduction
11.6.4 Virbac Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.6.5 Virbac Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Details
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Companion Animals Medicines and Vaccines Introduction
11.7.4 Dechra Veterinary Products Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Ceva Business Overview
11.8.3 Ceva Companion Animals Medicines and Vaccines Introduction
11.8.4 Ceva Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Companion Animals Medicines and Vaccines Introduction
11.9.4 Vetoquinol Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.9.5 Vetoquinol Recent Development
11.10 Meiji
11.10.1 Meiji Company Details
11.10.2 Meiji Business Overview
11.10.3 Meiji Companion Animals Medicines and Vaccines Introduction
11.10.4 Meiji Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.10.5 Meiji Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Details
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Companion Animals Medicines and Vaccines Introduction
11.11.4 Ouro Fino Saude Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.11.5 Ouro Fino Saude Recent Development
11.12 Parnell
11.12.1 Parnell Company Details
11.12.2 Parnell Business Overview
11.12.3 Parnell Companion Animals Medicines and Vaccines Introduction
11.12.4 Parnell Revenue in Companion Animals Medicines and Vaccines Business (2016-2021)
11.12.5 Parnell Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Companion Animals Medicines and Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicines
Table 3. Key Players of Vaccines
Table 4. Global Companion Animals Medicines and Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Companion Animals Medicines and Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Companion Animals Medicines and Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Companion Animals Medicines and Vaccines Market Share by Regions (2016-2021)
Table 8. Global Companion Animals Medicines and Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Companion Animals Medicines and Vaccines Market Share by Regions (2022-2027)
Table 10. Companion Animals Medicines and Vaccines Market Trends
Table 11. Companion Animals Medicines and Vaccines Market Drivers
Table 12. Companion Animals Medicines and Vaccines Market Challenges
Table 13. Companion Animals Medicines and Vaccines Market Restraints
Table 14. Global Companion Animals Medicines and Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Companion Animals Medicines and Vaccines Market Share by Players (2016-2021)
Table 16. Global Top Companion Animals Medicines and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Animals Medicines and Vaccines as of 2020)
Table 17. Ranking of Global Top Companion Animals Medicines and Vaccines Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Companion Animals Medicines and Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Animals Medicines and Vaccines Product Solution and Service
Table 21. Date of Enter into Companion Animals Medicines and Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Animals Medicines and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2016-2021)
Table 25. Global Companion Animals Medicines and Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Companion Animals Medicines and Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Companion Animals Medicines and Vaccines Revenue Market Share by Application (2016-2021)
Table 29. Global Companion Animals Medicines and Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Companion Animals Medicines and Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Companion Animals Medicines and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Companion Animals Medicines and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Companion Animals Medicines and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Companion Animals Medicines and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Companion Animals Medicines and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Companion Animals Medicines and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Companion Animals Medicines and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Companion Animals Medicines and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Companion Animals Medicines and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Companion Animals Medicines and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Companion Animals Medicines and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Companion Animals Medicines and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Companion Animals Medicines and Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Companion Animals Medicines and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Companion Animals Medicines and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Companion Animals Medicines and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Companion Animals Medicines and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Companion Animals Medicines and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Companion Animals Medicines and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Companion Animals Medicines and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Zoetis Company Details
Table 62. Zoetis Business Overview
Table 63. Zoetis Companion Animals Medicines and Vaccines Product
Table 64. Zoetis Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 65. Zoetis Recent Development
Table 66. Boehringer Ingelheim Company Details
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Companion Animals Medicines and Vaccines Product
Table 69. Boehringer Ingelheim Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Merck Animal Health Company Details
Table 72. Merck Animal Health Business Overview
Table 73. Merck Animal Health Companion Animals Medicines and Vaccines Product
Table 74. Merck Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 75. Merck Animal Health Recent Development
Table 76. Elanco Animal Health Company Details
Table 77. Elanco Animal Health Business Overview
Table 78. Elanco Animal Health Companion Animals Medicines and Vaccines Product
Table 79. Elanco Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 80. Elanco Animal Health Recent Development
Table 81. Bayer Animal Health Company Details
Table 82. Bayer Animal Health Business Overview
Table 83. Bayer Animal Health Companion Animals Medicines and Vaccines Product
Table 84. Bayer Animal Health Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 85. Bayer Animal Health Recent Development
Table 86. Virbac Company Details
Table 87. Virbac Business Overview
Table 88. Virbac Companion Animals Medicines and Vaccines Product
Table 89. Virbac Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 90. Virbac Recent Development
Table 91. Dechra Veterinary Products Company Details
Table 92. Dechra Veterinary Products Business Overview
Table 93. Dechra Veterinary Products Companion Animals Medicines and Vaccines Product
Table 94. Dechra Veterinary Products Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 95. Dechra Veterinary Products Recent Development
Table 96. Ceva Company Details
Table 97. Ceva Business Overview
Table 98. Ceva Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 99. Ceva Recent Development
Table 100. Vetoquinol Company Details
Table 101. Vetoquinol Business Overview
Table 102. Vetoquinol Companion Animals Medicines and Vaccines Product
Table 103. Vetoquinol Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 104. Vetoquinol Recent Development
Table 105. Meiji Company Details
Table 106. Meiji Business Overview
Table 107. Meiji Companion Animals Medicines and Vaccines Product
Table 108. Meiji Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 109. Meiji Recent Development
Table 110. Ouro Fino Saude Company Details
Table 111. Ouro Fino Saude Business Overview
Table 112. Ouro Fino Saude Companion Animals Medicines and Vaccines Product
Table 113. Ouro Fino Saude Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 114. Ouro Fino Saude Recent Development
Table 115. Parnell Company Details
Table 116. Parnell Business Overview
Table 117. Parnell Companion Animals Medicines and Vaccines Product
Table 118. Parnell Revenue in Companion Animals Medicines and Vaccines Business (2016-2021) & (US$ Million)
Table 119. Parnell Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Animals Medicines and Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Medicines Features
Figure 3. Vaccines Features
Figure 4. Global Companion Animals Medicines and Vaccines Market Share by Application: 2020 VS 2027
Figure 5. Dogs Case Studies
Figure 6. Cats Case Studies
Figure 7. Other Case Studies
Figure 8. Companion Animals Medicines and Vaccines Report Years Considered
Figure 9. Global Companion Animals Medicines and Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Companion Animals Medicines and Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Companion Animals Medicines and Vaccines Market Share by Regions: 2020 VS 2027
Figure 12. Global Companion Animals Medicines and Vaccines Market Share by Regions (2022-2027)
Figure 13. Global Companion Animals Medicines and Vaccines Market Share by Players in 2020
Figure 14. Global Top Companion Animals Medicines and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Animals Medicines and Vaccines as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Companion Animals Medicines and Vaccines Revenue in 2020
Figure 16. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2016-2021)
Figure 17. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type (2022-2027)
Figure 18. North America Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Companion Animals Medicines and Vaccines Market Share by Type (2016-2027)
Figure 20. North America Companion Animals Medicines and Vaccines Market Share by Application (2016-2027)
Figure 21. North America Companion Animals Medicines and Vaccines Market Share by Country (2016-2027)
Figure 22. United States Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Companion Animals Medicines and Vaccines Market Share by Type (2016-2027)
Figure 26. Europe Companion Animals Medicines and Vaccines Market Share by Application (2016-2027)
Figure 27. Europe Companion Animals Medicines and Vaccines Market Share by Country (2016-2027)
Figure 28. Germany Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Companion Animals Medicines and Vaccines Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Companion Animals Medicines and Vaccines Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Companion Animals Medicines and Vaccines Market Share by Region (2016-2027)
Figure 38. China Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Companion Animals Medicines and Vaccines Market Share by Type (2016-2027)
Figure 46. Latin America Companion Animals Medicines and Vaccines Market Share by Application (2016-2027)
Figure 47. Latin America Companion Animals Medicines and Vaccines Market Share by Country (2016-2027)
Figure 48. Mexico Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Companion Animals Medicines and Vaccines Market Share by Country (2016-2027)
Figure 54. Turkey Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Companion Animals Medicines and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Zoetis Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 59. Merck Animal Health Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 60. Elanco Animal Health Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 61. Bayer Animal Health Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 62. Virbac Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 63. Dechra Veterinary Products Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 64. Ceva Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 65. Vetoquinol Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 66. Meiji Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 67. Ouro Fino Saude Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 68. Parnell Revenue Growth Rate in Companion Animals Medicines and Vaccines Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の動物用医薬品＆ワクチン市場規模・現状・予測（2021年-2027年） In this report, we study veterinary Medicines and Vaccines Market Analysis and Insights: Global Veterinary Medicines and Vaccines Market The global Veterinary Medicines and Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…- 世界のペット用駆虫薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pets Parasiticide Medicines Market The global Pets Parasiticide Medicines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界の大麻ベース医薬品市場規模・現状・予測（2021年-2027年） Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food…
- 世界のアルテスネイト薬市場規模・現状・予測（2021年-2027年） Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria. Market Analysis and Insights: Global Artesunate Medicines Market The global Artesun…
- 世界のヒトDNAワクチン市場規模・現状・予測（2021年-2027年） DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…